Instant IP today announced the launch of Instant IP Teamsᴵᴾ (powered by Portfolios & Permissions), a major platform upgrade enabling law firms, enterprises, and institutions to collaboratively protect and manage intellectual property in real...
Boston Industrial Solutions, Inc., a global leader in advanced printing inks and ink products, is proud to announce the launch of the Natron® UVPZ Series, a new UV/LED-curing screen printing ink engineered to deliver the same outstanding performance as...
NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP Has a One-Day Depression Treatment, AI Monitoring Breakthrough, and Potential 2026 Drug Approval Put $NRXP in a Category of Its Own
The research will evaluate Ag5 in treatment-resistant non-small cell lung cancer. Collaboration targets patients who have exhausted Tagrisso® or KRAS inhibitor therapy - an area of critical unmet need with no approved standard of care
Joyful Nutritional, a leading innovator in advanced nutrient delivery systems, is proud to announce the official global launch of LiposoMore™, its premier brand of high-performance liposomal ingredients.
$LNAI is Deploying their patented AI architecture, launches national defense consortium, and accelerates 3-year antidote development model to capture $400M–$1.2B federal opportunities
In a defining moment for the future of civilization, Sahit Muja, Founder and CEO of Albanian Minerals, unveils a visionary framework poised to reshape the global economy: a $30 trillion regenerative system designed to transition humanity from extraction..
Miami-based supplement pioneer combines enteric-coated dihydroberberine with a patent-pending (U.S. App. No. 63/837,080) P-gp efflux modulator, targeting the two documented barriers to berberine absorption that most supplements never address
1308 views, By Innovative Environmental Technologies, Inc.
New digital platform highlights IET's leadership in remediation and drilling while introducing free AI-powered tools for environmental site review, data analysis, report evaluation, and smarter project planning
Xycota Biosciences, LLC ("Xycota"), an early-stage biotechnology company focused on brain repair therapeutics, today announced the formal unveiling of its neuro-restoration platform, anchored by newly published mechanistic evidence in the Nature...
87% Clinical Response From Non-Invasive Neuroplastic Therapy Positions $NRXP at the Forefront of Next-Generation Mental Health Treatment. NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP)
Breathe Biologics, Inc. is a regenerative medicine company focused on lung diseases using licensed and patented umbilical cord tissue derived multi-potent mesenchymal stem cell, termed "JadiCell."
Postmortem Pathology announces the expansion of its independent autopsy services throughout the greater Kansas City metropolitan area and surrounding counties.
Proposed five-year agreement positions Covalent Medical to commercialize ClearSight's OTC Artificial Tears+, Contact Lens Rewetting Drops, and Pink Eye portfolio across physician-dispensed and national retail channels, with launch targeted for Q1 2027...
Capsadyn®, a maximum-strength non-burning capsaicin cream developed by Chorda Pharma Inc., is now available on Amazon in addition to direct sales through Capsadyn.com.
A profound shift is unfolding at the foundations of the global economy, one that could redefine not only how humanity produces energy and materials, but how civilization itself grows.
The world is investing trillions in artificial intelligence, elevating it to strategic infrastructure. Corporations reorganize around it, governments prioritize it, and financial markets assign it extraordinary value.
Instant IP today announced the launch of Instant IP Teamsᴵᴾ (powered by Portfolios & Permissions), a major platform upgrade enabling law firms, enterprises, and institutions to collaboratively protect and manage intellectual property in real...
Boston Industrial Solutions, Inc., a global leader in advanced printing inks and ink products, is proud to announce the launch of the Natron® UVPZ Series, a new UV/LED-curing screen printing ink engineered to deliver the same outstanding performance as...
NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP Has a One-Day Depression Treatment, AI Monitoring Breakthrough, and Potential 2026 Drug Approval Put $NRXP in a Category of Its Own
The research will evaluate Ag5 in treatment-resistant non-small cell lung cancer. Collaboration targets patients who have exhausted Tagrisso® or KRAS inhibitor therapy - an area of critical unmet need with no approved standard of care
Apelo Consulting has released a report on "Global Bionic Devices Market (By Product, Fixation, Technology, End User, Country Analysis), Key Company Profiles, Trends and Recent Developments – Forecast to 2030"
Joyful Nutritional, a leading innovator in advanced nutrient delivery systems, is proud to announce the official global launch of LiposoMore™, its premier brand of high-performance liposomal ingredients.
$LNAI is Deploying their patented AI architecture, launches national defense consortium, and accelerates 3-year antidote development model to capture $400M–$1.2B federal opportunities
Kernexus Medical Communications today announced that it will launch the Advanced Wound Care Summit (AWCS) at Tissue Repair Summit Spring (TRSS), taking place May 14–15, 2026 at the Marriott Downtown in Austin, Texas.
In a defining moment for the future of civilization, Sahit Muja, Founder and CEO of Albanian Minerals, unveils a visionary framework poised to reshape the global economy: a $30 trillion regenerative system designed to transition humanity from extraction..
Biosurgery Market size valued at USD 13.7 billion in 2022 is projected to reach USD 28.5 billion by 2032 at 7.8% CAGR. Explore Biosurgery Market Share, Growth, Trends, Analysis, and Forecast in the latest market report.
For more than a century, global progress has been defined by extraction. Mountains were hollowed, rivers redirected, forests erased, and oceans stretched to their limits in pursuit of growth.
Miami-based supplement pioneer combines enteric-coated dihydroberberine with a patent-pending (U.S. App. No. 63/837,080) P-gp efflux modulator, targeting the two documented barriers to berberine absorption that most supplements never address
1308 views, By Innovative Environmental Technologies, Inc.
New digital platform highlights IET's leadership in remediation and drilling while introducing free AI-powered tools for environmental site review, data analysis, report evaluation, and smarter project planning
Xycota Biosciences, LLC ("Xycota"), an early-stage biotechnology company focused on brain repair therapeutics, today announced the formal unveiling of its neuro-restoration platform, anchored by newly published mechanistic evidence in the Nature...
Intravenous Immunoglobulin Market is projected to reach USD 24.4 billion by 2032 with a 7.6% CAGR. Explore insights on Intravenous Immunoglobulin Market Size, Share, Growth, Trends, and Analysis driven by rising immunodeficiency treatments worldwide.
The full conference program for INTERPHEX WEEK TOKYO 2026, Japan's largest pharma and biotech gathering has been officially published ahead of the event taking place May 20 (Wed)–22 (Fri), 2026 at Makuhari Messe in Chiba, Japan, bringing together an...
87% Clinical Response From Non-Invasive Neuroplastic Therapy Positions $NRXP at the Forefront of Next-Generation Mental Health Treatment. NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP)
Apelo Consulting has released a report on "Global AI in Precision Medicine Market (By Technology, Component, Application and Region), Company Profiles, and Market Dynamics – Forecast to 2032"
Biomimetic Materials Market is projected to reach USD 72.7 Billion by 2032 growing at a CAGR of 6.4%. Discover market size, share, trends, growth drivers, and leading companies shaping the global biomimetic materials industry.
Humanity faces an unprecedented crossroads. Every year, ten million lives are lost to pollution, extreme climate events, and collapsing ecosystems, while the global economy bleeds eight trillion dollars in healthcare, disaster recovery, and lost...
Breathe Biologics, Inc. is a regenerative medicine company focused on lung diseases using licensed and patented umbilical cord tissue derived multi-potent mesenchymal stem cell, termed "JadiCell."
